Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.

Berman JR, Berman LA, Toler SM, Gill J, Haughie S; Sildenafil Study Group.

J Urol. 2003 Dec;170(6 Pt 1):2333-8.

PMID:
14634409
2.

The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Krapf JM, Simon JA.

Maturitas. 2009 Jul 20;63(3):213-9. doi: 10.1016/j.maturitas.2009.04.008. Epub 2009 May 31. Review.

PMID:
19487090
3.

Sildenafil citrate for female sexual arousal disorder: a future possibility?

Schoen C, Bachmann G.

Nat Rev Urol. 2009 Apr;6(4):216-22. doi: 10.1038/nrurol.2009.25. Review.

PMID:
19352396
4.
5.

Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction.

Brown DA, Kyle JA, Ferrill MJ.

Ann Pharmacother. 2009 Jul;43(7):1275-85. doi: 10.1345/aph.1L691. Epub 2009 Jun 9. Review.

PMID:
19509350
7.

Use of sildenafil for female sexual dysfunction.

Shields KM, Hrometz SL.

Ann Pharmacother. 2006 May;40(5):931-4. Epub 2006 Apr 18. Review.

PMID:
16622158
8.

Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.

King R, Juenemann KP, Levinson IP, Stecher VJ, Creanga DL.

Int J Impot Res. 2007 Jul-Aug;19(4):398-406. Epub 2007 Mar 15. Review.

PMID:
17361232
9.

Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials.

Modelska K, Cummings S.

Am J Obstet Gynecol. 2003 Jan;188(1):286-93. Review.

PMID:
12548231
10.

Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Davis SR, Braunstein GD.

J Sex Med. 2012 Apr;9(4):1134-48. doi: 10.1111/j.1743-6109.2011.02634.x. Epub 2012 Feb 3. Review.

PMID:
22304681
11.

Sexual dysfunction and depression.

Seidman SN, Roose SP.

Curr Psychiatry Rep. 2001 Jun;3(3):202-8. Review.

PMID:
11353583
12.

Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women.

Palacios S.

Womens Health (Lond Engl). 2011 Jan;7(1):95-107. doi: 10.2217/whe.10.81. Review.

13.

The impact of the new sexual pharmaceuticals on sex therapy.

Perelman MA.

Curr Psychiatry Rep. 2001 Jun;3(3):195-201. Review.

PMID:
11353582
14.

Testosterone supplementation for hypoactive sexual desire disorder in women.

Woodis CB, McLendon AN, Muzyk AJ.

Pharmacotherapy. 2012 Jan;32(1):38-53. doi: 10.1002/PHAR.1004. Review.

PMID:
22392827
15.

The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Kingsberg SA, Simon JA, Goldstein I.

J Sex Med. 2008 Sep 2;5 Suppl 4:182-93; quiz 193. doi: 10.1111/j.1743-6109.2008.00961.x. Review.

PMID:
18783534
16.

Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors.

Shen WW, Urosevich Z, Clayton DO.

J Reprod Med. 1999 Jun;44(6):535-42. Review.

PMID:
10394548
17.

Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.

Warnock JK, Bundren JC, Morris DW.

Psychopharmacol Bull. 1997;33(4):761-6. Review.

PMID:
9493489
18.

Menopause and sexual desire: the role of testosterone.

Nappi RE, Albani F, Santamaria V, Tonani S, Martini E, Terreno E, Brambilla E, Polatti F.

Menopause Int. 2010 Dec;16(4):162-8. doi: 10.1258/mi.2010.010041. Review.

PMID:
21156854
19.

Female sexual dysfunction.

Walton B, Thorton T.

Curr Womens Health Rep. 2003 Aug;3(4):319-26. Review.

PMID:
12844457
20.

Advances in pharmacotherapy for treating female sexual dysfunction.

Nappi RE, Cucinella L.

Expert Opin Pharmacother. 2015 Apr;16(6):875-87. doi: 10.1517/14656566.2015.1020791. Epub 2015 Mar 2. Review.

PMID:
25732267
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk